Table 7. . Urinary acetylamantadine concentration in healthy adult volunteers recruited locally at Asper Clinical Research Institute (Winnipeg site).

Subject ID	2 h [AA] (ng/ml)	Urine (ml)	Total AA (ng)	4 h [AA] (ng/ml)	Urine (ml)	Total AA (ng)	6 h [AA] (ng/ml)	Urine (ml)	Total AA (ng)
BM0001	2.0	220	429	2.2	205	445	3.5	130	452
BM0002†	10.5	20	210	10.6	40	424	10.7	75	803
BM0003†	1.7	180	297	3.4	238	809	1.4	228	309
BM0004†	1.1	410	442	2.8	320	880	4.5	130	589
BM0005†	3.8	40	152	3.2	190	614	1.4	180	252
BM0006†	1.2	85	99	8.7	145	1260	2.0	165	333
BM0007†	3.0	165	501	14.9	120	1788	4.0	175	707
BM0008	1.6	190	296	1.7	205	344	5.0	170	841
BM0009†	3.9	170	660	9.2	130	1191	5.8	210	1210
BM0010	1.1	7	8	0.8	120	99	0.4	100	42
BM0011†	0.8	410	314	3.2	400	1288	1.7	390	655
BM0021†	2.7	220	603	9.3	460	4264	5.3	190	1005
BM0022	2.3	90	207	2.0	95	194	2.1	100	211
BM0023	0.6	315	201	3.3	85	282	2.4	155	369
BM0024	4.4	55	239	4.6	90	413	4.4	130	569
BM0025	1.4	50	69	4.0	50	198	2.3	100	229
BM0026†	0.6	245	142	2.6	305	790	3.5	75	264
BM0027	5.2	160	837	4.4	80	353	4.6	130	593
BM0028†	3.8	220	834	10.7	100	1070	14.8	115	1702
BM0029	4.6	120	550	5.8	100	575	4.5	140	631

^†Identified as an outlier based on total AA amount (ng) at 4 h time point of more than 600 ng or concentration of AA more than 6.0 ng/ml.

AA: Acetylamantadine.